Winton Group LTD Allogene Therapeutics, Inc. Transaction History

Winton Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $11,074 - $18,480	2,251 Added 6.43%	37,255 $184,000
Q4 2022 Feb 14, 2023	BUY	$5.62 - $11.11 $9,677 - $19,131	1,722 Added 5.17%	35,004 $220,000
Q3 2022 Nov 10, 2022	SELL	$10.32 - $17.28 $55,377 - $92,724	-5,366 Reduced 13.88%	33,282 $359,000
Q2 2022 Aug 10, 2022	BUY	$6.78 - $12.28 $55,446 - $100,425	8,178 Added 26.84%	38,648 $441,000
Q1 2022 May 11, 2022	BUY	$7.65 - $15.29 $45,219 - $90,379	5,911 Added 24.07%	30,470 $278,000
Q4 2021 Feb 10, 2022	SELL	$13.13 - $24.52 $71,597 - $133,707	-5,453 Reduced 18.17%	24,559 $366,000
Q3 2021 Oct 28, 2021	SELL	$21.01 - $27.64 $34,750 - $45,716	-1,654 Reduced 5.22%	30,012 $771,000
Q2 2021 Aug 10, 2021	BUY	$23.49 - $35.8 $276,171 - $420,900	11,757 Added 59.05%	31,666 $826,000
Q1 2021 Jul 21, 2021	SELL	$25.79 - $39.02 $65,377 - $98,915	-2,535 Reduced 11.29%	19,909 $703,000
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $1.68 Million - $2.9 Million	-66,719 Reduced 74.83%	22,444 $566,000
Q3 2020 Oct 30, 2020	BUY	$32.38 - $44.96 $1.14 Million - $1.58 Million	35,123 Added 64.99%	89,163 $3.36 Million
Q2 2020 Aug 05, 2020	BUY	$18.39 - $54.04 $107,250 - $315,161	5,832 Added 12.1%	54,040 $2.31 Million
Q1 2020 May 11, 2020	BUY	$18.22 - $28.25 $120,871 - $187,410	6,634 Added 15.96%	48,208 $937,000
Q4 2019 Feb 13, 2020	BUY	$24.82 - $31.4 $1.03 Million - $1.31 Million	41,574 New	41,574 $1.08 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.